the Nomura report is just out on the PRR website and they give a good response to yesterday's findings for CAN3 trials so far.
They maintain a price of 32c.
I remain committed to this stock and don't see any of the negativity that others seem to have in the results and their implications. If fact I am delighted with the outcomes so far and agree with Meg's sentiments
cheers
Birdseye
result continues to add confidence
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.005(1.72%) |
Mkt cap ! $428.5M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 29.8¢ | 29.0¢ | $539.5K | 1.834M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 214062 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 469318 | 5 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |